| abstract |
Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed. In particular the application is directed to a pharmaceutical formulation comprising (a), at least one analogue and/or derivative of insulin; and (b). Zn(ll); and (c). sorbitol; and (d). optionally protamine. |